Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study

por Donswijk, Maarten L., van Leeuwen, Pim J., Vegt, Erik, Cheung, Zing, Heijmink, Stijn W. T. P. J., van der Poel, Henk G., Stokkel, Marcel P. M.
Publicado 2020

Impact of contrast agent injection duration on dynamic contrast‐enhanced MRI quantification in prostate cancer

por Klawer, Edzo M.E., van Houdt, Petra J., Pos, Floris J., Heijmink, Stijn W.T.P.J., van Osch, Matthias J.P., van der Heide, Uulke A.
Publicado 2018

Improved repeatability of dynamic contrast‐enhanced MRI using the complex MRI signal to derive arterial input functions: a test‐retest study in prostate cancer patients

por Klawer, Edzo M.E., van Houdt, Petra J., Simonis, Frank F.J., van den Berg, Cornelis A.T., Pos, Floris J., Heijmink, Stijn W.T.P.J., Isebaert, Sofie, Haustermans, Karin, van der Heide, Uulke A.
Publicado 2019

Prostate MRI for Improving Personalized Risk Prediction of Incontinence and Surgical Planning: The Role of Membranous Urethral Length Measurements and the Use of 3D Models

por Boellaard, Thierry N., Hagens, Marinus J., Veerman, Hans, Yakar, Derya, Mertens, Laura S., Heijmink, Stijn W. T. P. J., van der Poel, Henk G., van Leeuwen, Pim J., Schoots, Ivo G., van Dijk-de Haan, Margriet C.
Publicado 2023

Quantitative 3-T multi-parametric MRI and step-section pathology of recurrent prostate cancer patients after radiation therapy

por Dinis Fernandes, Catarina, Ghobadi, Ghazaleh, van der Poel, Henk G., de Jong, Jeroen, Heijmink, Stijn W. T. P. J., Schoots, Ivo, Walraven, Iris, van Houdt, Petra J., Smolic, Milena, Pos, Floris J., van der Heide, Uulke A.
Publicado 2018

Quantitative 3T multiparametric MRI of benign and malignant prostatic tissue in patients with and without local recurrent prostate cancer after external‐beam radiation therapy

por Dinis Fernandes, Catarina, van Houdt, Petra J., Heijmink, Stijn W.T.P.J., Walraven, Iris, Keesman, Rick, Smolic, Milena, Ghobadi, Ghazaleh, van der Poel, Henk G., Schoots, Ivo G., Pos, Floris J., van der Heide, Uulke A.
Publicado 2018

IMPemBra: a phase 2 study comparing pembrolizumab with intermittent/short-term dual MAPK pathway inhibition plus pembrolizumab in patients with melanoma harboring the BRAFV600 muta...

por Rozeman, Elisa A, Versluis, Judith M, Sikorska, Karolina, Hoefsmit, Esmée P, Dimitriadis, Petros, Rao, Disha, Lacroix, Ruben, Grijpink-Ongering, Lindsay G, Lopez-Yurda, Marta, Heeres, Birthe C, van de Wiel, Bart A, Flohil, Claudie, Sari, Aysegul, Heijmink, Stijn W T P J, van den Broek, Daan, Broeks, Annegien, de Groot, Jan Willem B, Vollebergh, Marieke A, Wilgenhof, Sofie, van Thienen, Johannes V, Haanen, John B A G, Blank, Christian U
Publicado 2023